Login / Signup
Imatinib and CAR T cell therapy enable sustained response in a young patient with refractory RCSD1-ABL1-positive acute lymphoblastic leukemia.
Yajuan Cui
Hong-Ling Peng
Published in:
Annals of hematology (2023)
Keyphrases
</>
cell therapy
acute lymphoblastic leukemia
chronic myeloid leukemia
stem cells
mesenchymal stem cells
case report
allogeneic hematopoietic stem cell transplantation
tyrosine kinase
middle aged
bone marrow